ISTH/SSC出血评估工具在遗传性血小板疾病中的验证
该研究纳入1098名受试者(482例遗传性血小板疾病,包括196例遗传性血小板功能缺陷和286例遗传性血小板数量疾病),比较ISTH-BAT在遗传性血小板功能缺陷(IPFD)与1型血管性血友病(VWD-1)及健康对照(HC)中的鉴别能力。IPFD患者出血评分中位数9,高于VWD-1的5;ISTH-BAT对IPFD与HC的鉴别力极好(AUC 0.9-1),对IPFD与VWD-1或遗传性血小板减少症的鉴别力中等(AUC 0.7-0.9)。
要点
- IPFD患者出血评分中位数9,高于VWD-1的5。
- ISTH-BAT对IPFD与健康对照鉴别力极好(AUC 0.9-1)。
- 对IPFD与VWD-1鉴别力中等(AUC 0.7-0.9)。
核心结论
- ISTH-BAT能有效区分IPFD与健康对照,但区分IPFD与VWD-1的准确性较低。
- 在初步排除VWD后,ISTH-BAT有助于识别需要实验室评估的可疑IPFD患者。
研究设计与样本
- 多国队列研究,纳入1098名受试者,来自17个国家,其中482例遗传性血小板疾病(196例IPFD和286例遗传性血小板数量疾病)。
- 比较IPFD与VWD-1患者及健康对照的ISTH-BAT表现。
主要发现
- IPFD患者出血评分中位数9,显著高于VWD-1患者的5。
- IPFD患者出血症状数量中位数4,多于VWD-1患者的3。
- IPFD患者中临床相关症状(评分>2)的比例更高。
- ISTH-BAT区分IPFD与健康对照的AUC在0.9到1之间。
- ISTH-BAT区分IPFD与VWD-1或遗传性血小板减少症的AUC在0.7到0.9之间,区分遗传性血小板减少症与健康对照的AUC≤0.7。
关键数值与推荐
- IPFD患者出血评分中位数9,VWD-1患者中位数5。
- IPFD患者出血症状数量中位数4,VWD-1患者中位数3。
- ISTH-BAT区分IPFD与健康对照的AUC>0.9且<1。
- ISTH-BAT区分IPFD与VWD-1的AUC>0.7且<0.9。
- ISTH-BAT区分IPFD与遗传性血小板减少症的AUC>0.7且<0.9。
临床怎么用
- 在怀疑遗传性血小板功能缺陷时,可先排除血管性血友病,再使用ISTH-BAT评估出血症状。
- ISTH-BAT评分有助于识别需要进一步实验室检查的IPFD患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Careful assessment of bleeding history is the first step in the evaluation of patients with mild/moderate bleeding disorders, and the use of a bleeding assessment tool (BAT) is strongly encouraged. Although a few studies have assessed the utility of the ISTH-BAT in patients with inherited platelet function disorders (IPFD) none of them was sufficiently large to draw conclusions and/or included appropriate control groups. OBJECTIVES: The aim of the present study was to test the utility of the ISTH-BAT in a large cohort of patients with a well-defined diagnosis of inherited platelets disorder in comparison with two parallel cohorts, one of patients with type-1 von Willebrand disease (VWD-1) and one of healthy controls (HC). PATIENTS/METHODS: We enrolled 1098 subjects, 482 of whom had inherited platelet disorders (196 IPFD and 286 inherited platelet number disorders [IT]) from 17 countries. RESULTS: IPFD patients had significantly higher bleeding score (BS; median 9) than VWD-1 patients (median 5), a higher number of hemorrhagic symptoms (4 versus 3), and higher percentage of patients with clinically relevant symptoms (score > 2). The ISTH-BAT showed excellent discrimination power between IPFD and HC (0.9 < area under the curve [AUC] < 1), moderate (0.7 < AUC < 0.9) between IPFD and VWD-1 and between IPFD and inherited thrombocytopenia (IT), while it was inaccurate (AUC ≤ 0.7) in discriminating IT from HC. CONCLUSIONS: The ISTH-BAT allows to efficiently discriminate IPFD from HC, while it has lower accuracy in distinguishing IPFD from VWD-1. Therefore, the ISTH-BAT appears useful for identifying subjects requiring laboratory evaluation for a suspected IPFD once VWD is preliminarily excluded.
引用
- Gresele P, Orsini S, Noris P, et al. Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC. J Thromb Haemost. 2019. PMID: 31750621. doi:10.1111/jth.14683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。